Bone Biologics Corp company info

CIK 1419554
IRS Number 421743430
State of incorporation DE
Business address 2 BURLINGTON WOODS DRIVE,
SUITE 100,
BURLINGTON
MA
01803
Mail address 2 BURLINGTON WOODS DRIVE,
SUITE 100,
BURLINGTON
MA
01803

Short summary

Bone Biologics Corp is a Massachusetts company, with head office located at 2 Burlington Woods Drive, Burlington, Massachusetts 01803. In 2019 the company owned a total of 249.34 thousand USD worth of assets, including 249.34 thousand USD worth of current assets. 2014 was the year when the company amassed the most assets.

Bone Biologics Corp Income Statement

Name [in Millions USD]20032004200520062007200820092010201120122013201420152016201720182019Trends
Gross Profit
Research and development 0.190.623.6711.60-1.190.10
Operating Expenses 0.000.000.010.673.0112.0017.852.632.79
Operating Income (Loss) -0.67-3.01-12.00-17.85-2.63-2.79
Interest expense 0.411.400.11
Income Tax Expense (Benefit) 0.000.000.010.000.000.00
Net income -0.05-0.48-1.22-1.00-1.20-0.90-0.94-0.72-1.08-4.42-13.88-21.03-7.05-4.43

Bone Biologics Corp Balance Sheet

Name [in Millions USD]20032004200520062007200820092010201120122013201420152016201720182019Trends
Cash and cash equivalents 00.040.003.172.190.780.300.180.20
Property, Plant and Equipment, Gross 0.010.000.000.00
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment 0.000.000.000.00
Total assets 00.000.134.412.331.140.380.270.25
Current assets 0.134.402.631.140.380.270.25
Accounts payable 0.030.270.110.260.180.14
Total current liabilities 6.340.042.304.511.2711.1211.63
Total liabilities 0.020.030.046.345.317.7110.549.839.64
Common Stock, Value, Issued 0.010.010.010.000.030.040.040.000.030.03
Retained Earnings (Accumulated Deficit) -0.05-0.060.06-8.36-14.5743.2154.04-61.90-65.95-66.51

Bone Biologics Corp Cash Flow

Name [in Millions USD]20032004200520062007200820092010201120122013201420152016201720182019Trends
Net income -0.05-0.48-1.22-1.00-1.20-0.90-0.94-0.72-1.08-4.42-13.88-21.03-7.05-4.43
Depreciation 00.000.000.000.000.00
Deferred Income Tax Expense (Benefit)
Net Cash Provided by (Used in) Operating Activities -0.01-0.00-0.01-0.53-2.76-3.55-7.33-3.33-4.10
Payments to Acquire Property, Plant, and Equipment 0.010.00
Net Cash Provided by (Used in) Investing Activities 0.03-0.00
Proceeds from Stock Plans 0.01
Proceeds from Issuance of Common Stock 0.482.500.704.37
Net Cash Provided by (Used in) Financing Activities 0.010.000.010.525.3926.833.404.37
Cash and Cash Equivalents, Period Increase (Decrease) 0.00-0.002.66-1.55-0.490.070.27